Position in NBIX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$19,712,387
+$8,348,259 QoQ
Shares Held
149,631
+86.7% QoQ
Ownership
0.149%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
13 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Derivatives in NBIX
reported options exposure · as of Mar 31, 2020CallValue
$657,780
CallShares
7,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026CAPITAL FUND MANAGEMENT S.A. holds $92,308,096 across 12 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (21.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
48,964 | $29,034,672 | |
| 2 | ZTS |
Zoetis Inc.
|
190,415 | $22,508,957 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
This page
|
149,631 | $19,712,387 | |
| 4 | ALKS |
Alkermes plc.
|
243,043 | $8,594,000 | |
| 5 | HLN |
Haleon plc
|
421,051 | $4,214,720 | |
| 6 | PRGO |
PERRIGO Co plc
|
277,003 | $2,975,012 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
29,715 | $1,535,968 | |
| 8 | LQDA |
Liquidia Corp
|
34,222 | $1,291,538 |
All Filings in NBIX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,712,387 | 149,631 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $11,364,128 | 80,125 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $17,365,567 | 123,704 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $25,594,003 | 203,628 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $19,425,894 | 175,641 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $14,267,526 | 104,524 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $12,855,325 | 111,572 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $7,840,444 | 56,951 | Shares | Sole | 2024-08-13 | |
| 2021-03-31 | $5,860,868 | 60,266 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,903,293 | 19,857 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,179,658 | 22,667 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,359,236 | 19,338 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,046,301 | 23,643 | Shares | Sole | 2020-05-13 | |
| 2020-03-31 | $657,780 | 7,600 | Call | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||